Clinical trial
Risperidone in the Treatment of Behavioral Disturbances in Demented Patients: an International, Multicenter, Placebo-controlled, Double-blind, Parallel-group Trial Using Haloperidol as Internal Reference
NCT00249145 is registered in ClinicalTrials.gov with Janssen Pharmaceutica N.V., Belgium as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Risperidone in the Treatment of Behavioral Disturbances in Demented Patients: an International, Multicenter, Placebo-controlled, Double-blind, Parallel-group Trial Using Haloperidol as Internal Reference
- Lead sponsor
- Janssen Pharmaceutica N.V., Belgium
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 30, 1995
- Completion date
- December 31, 1996
- Enrollment
- 349 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.